Polivy (polatuzumab vedotin) 140 mg powder for concentrate for solution for injection: Important information on plastic vial flip-off cap colour
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Polivy
|
| Active substance |
polatuzumab vedotin
|
| Therapeutic area (MeSH) |
Lymphoma, B-Cell
|
| Procedure number |
EMEA/H/C/004870
|
| DHPC type |
Quality defect
|
| Human ATC code |
L01FX
|